386 related articles for article (PubMed ID: 15074473)
21. Ratio of urinary free immunoglobulin light chain kappa to lambda in the diagnosis of Bence Jones proteinuria.
Nakano T; Nagata A; Takahashi H
Clin Chem Lab Med; 2004 Apr; 42(4):429-34. PubMed ID: 15147154
[TBL] [Abstract][Full Text] [Related]
22. Biochemical profile of Bence-Jones type multiple myeloma.
Lyubimova NV; Timofeev YS; Abaev VM; Votyakova OM; Osmanov EA; Kushlinskii NE
Klin Lab Diagn; 2022 Oct; 67(10):570-574. PubMed ID: 36315171
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder.
Vermeersch P; Van Hoovels L; Delforge M; Mariën G; Bossuyt X
Br J Haematol; 2008 Nov; 143(4):496-502. PubMed ID: 18729849
[TBL] [Abstract][Full Text] [Related]
24. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
25. Idiopathic light-chain proteinuria: case report and review of the literature.
Audard V; Damaj G; Rubio MT; Aucouturier P; Hermine O; Varet B
Am J Hematol; 2004 Jul; 76(3):293-4. PubMed ID: 15224371
[TBL] [Abstract][Full Text] [Related]
26. Double Bence Jones proteinuria.
Kanoh T; Yago K
Arch Pathol Lab Med; 1990 Sep; 114(9):991-4. PubMed ID: 2117911
[TBL] [Abstract][Full Text] [Related]
27. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population.
Abadie JM; Bankson DD
Ann Clin Lab Sci; 2006; 36(2):157-62. PubMed ID: 16682511
[TBL] [Abstract][Full Text] [Related]
28. [Laboratory diagnosis of monoclonal gammopathies. Prospective study of 14 cases in Dakar, Senegal].
Diop PA; Haudrechy D; Sylla-Niang M; Diedhiou A; Ngom L; Lopez-Sall P
Bull Soc Pathol Exot; 1998; 91(3):242-6. PubMed ID: 9773201
[TBL] [Abstract][Full Text] [Related]
29. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
[TBL] [Abstract][Full Text] [Related]
30. κ and λ urine free light chains: a new method for quantification.
Giussani M; Ciniselli CM; Macciotta A; Panella R; Verderio P; Bonini C; Morelli D
Tumori; 2020 Dec; 106(6):457-463. PubMed ID: 31955649
[TBL] [Abstract][Full Text] [Related]
31. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases.
Tate JR; Mollee P; Dimeski G; Carter AC; Gill D
Clin Chim Acta; 2007 Feb; 376(1-2):30-6. PubMed ID: 16945362
[TBL] [Abstract][Full Text] [Related]
32. Immunoglobulin light-chain immunoblots of urine proteins from patients with tubular and Bence-Jones proteinuria.
Norden AG; Fulcher LM; Flynn FV
Clin Chim Acta; 1987 Jul; 166(2-3):307-15. PubMed ID: 3113774
[TBL] [Abstract][Full Text] [Related]
33. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy].
Shimazaki C; Murakami H; Sawamura M; Matsuda M; Kinoshita T; Hata H; Sugiura I; Tsushita K; Nagura E; Kosugi H; Itoh J; Shimizu K
Rinsho Ketsueki; 2010 Apr; 51(4):245-52. PubMed ID: 20467220
[TBL] [Abstract][Full Text] [Related]
34. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
Akar H; Seldin DC; Magnani B; O'Hara C; Berk JL; Schoonmaker C; Cabral H; Dember LM; Sanchorawala V; Connors LH; Falk RH; Skinner M
Amyloid; 2005 Dec; 12(4):210-5. PubMed ID: 16399645
[TBL] [Abstract][Full Text] [Related]
35. Guidelines for the analysis of Bence Jones protein.
Graziani M; Merlini G; Petrini C; ;
Clin Chem Lab Med; 2003 Mar; 41(3):338-46. PubMed ID: 12705344
[TBL] [Abstract][Full Text] [Related]
36. An immunoblotting procedure following agarose gel electrophoresis for detection of Bence Jones proteinuria compared with immunofixation and quantitative light chain determination.
Withold W; Reinauer H
Eur J Clin Chem Clin Biochem; 1995 Mar; 33(3):135-8. PubMed ID: 7605825
[TBL] [Abstract][Full Text] [Related]
37. An algorithmic approach using kappa/lambda ratios to improve the diagnostic accuracy of urine protein electrophoresis and to reduce the volume required for immunoelectrophoresis.
Levinson SS
Clin Chim Acta; 1997 Jun; 262(1-2):121-30. PubMed ID: 9204214
[TBL] [Abstract][Full Text] [Related]
38. IgA lambda monoclonal gammopathy with Bence Jones proteinuria and intestinal plasmacytoma in a renal transplant recipient.
Pascali E; Pezzoli A
Quad Sclavo Diagn; 1987 Dec; 23(4):363-8. PubMed ID: 3149785
[No Abstract] [Full Text] [Related]
39. Quantification of β region IgA paraproteins - should we include immunochemical "heavy/light chain" measurements? Counterpoint.
Paolini L
Clin Chem Lab Med; 2016 Jun; 54(6):1059-64. PubMed ID: 26812795
[TBL] [Abstract][Full Text] [Related]
40. Serum free light chain analysis may miss monoclonal light chains that urine immunofixation electrophoreses would detect.
Shaheen SP; Levinson SS
Clin Chim Acta; 2009 Aug; 406(1-2):162-6. PubMed ID: 19410572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
